XML 42 R25.htm IDEA: XBRL DOCUMENT
v3.22.4

Note 16 | 12 Months Ended
--- | ---
Dec. 31, 2022
Investments in subsidiaries, joint ventures and associates reported in separate financial statements [abstract] |
Disclosure of Investments In Subsidiaries Joint Ventures And Associates [Text Block] | Investments in joint ventures and associates Joint ventures and associates The breakdown of the balance of “Investments in joint ventures and associates” in the consolidated balance sheets is as follows:
Joint ventures and associates. Breakdown by entities (Millions of Euros) |
Joint ventures | 2022 | 2021 | 2020
Altura Markets, S.V., S.A. | 42 | 76 | 77
RCI Colombia | 36 | 40 | 36
Desarrollo Metropolitanos del Sur, S.L. | — | 18 | 17
Other | 22 | 18 | 19
Subtotal | 100 | 152 | 149
Associates |  |  |
Divarian Propiedad, S.A.U. | — | — | 567
Metrovacesa, S.A. | 259 | 259 | 285
BBVA Allianz Seguros y Reaseguros, S.A. | 248 | 254 | 250
Atom Holdco Ltd | 132 | 77 | 64
Solaris SE | 66 | 61 | 39
Cofides | 31 | 28 | 25
Redsys servicios de procesamiento, S.L. | 20 | 19 | 14
Servicios Electrónicos Globales S.A. de CV | 23 | 15 | 11
Other | 37 | 35 | 33
Subtotal | 816 | 749 | 1,288
Total | 916 | 900 | 1,437
Details of the joint ventures and associates as of December 31, 2022 are shown in Appendix II. The following is a summary of the changes in the years ended December 31, 2022, 2021 and 2020 under this heading in the consolidated balance sheets:
Joint ventures and associates. Changes in the year (Millions of Euros)
| Notes | 2022 | 2021 | 2020
Balance at the beginning |  | 900 | 1,437 | 1,488
Acquisitions and capital increases |  | 87 | 22 | 257
Disposals and capital reductions |  | (88) | (1) | (47)
Transfers and changes of consolidation method |  | — | (559) | (7)
Share of profit and loss | 39 | 20 | 1 | (39)
Exchange differences |  | (1) | 9 | (27)
Dividends, valuation adjustments and others |  | (2) | (9) | (188)
Balance at the end |  | 916 | 900 | 1,437
During the year 2022, the most significant changes under the heading "Investment in joint ventures and associates" correspond to capital increases in Atom Holdco Limited. During the year 2022 Atom Holdco Limited, the owner of 100% of the shares of Atom Bank PLC, was created. BBVA became a shareholder of Atom Holdco Limited under the same terms and conditions as those previously applicable under the agreement with Atom Bank PLC. During the year 2021, the most significant changes in the heading “Investment in joint ventures and associates” correspond to the reclassification of the 20% stake in Divarian Property, S.A.U. under the heading "Non-current assets and disposal groups classified as held for sale" in July 2021 and their subsequent sale in October 2021 (see Note 21). During the year 2020, the most significant changes in the heading “Investments in joint ventures and associates” correspond to changes in the valuation of Metrovacesa and BBVA Allianz Seguros y Reaseguros, S.A. Appendix III provides notifications on acquisitions and disposals of holdings in subsidiaries, joint ventures and associates, in compliance with article 155 of the Corporations Act and article 125 of the Securities Market Act 4/2015. Other information about associates and joint ventures If these entities had been consolidated rather than accounted for using the equity method, the change in each of the lines of balance sheet and the consolidated income statement would not be significant. As of December 31, 2022, 2021 and 2020 there was no financial support agreement or other contractual commitment to associates and joint ventures entities from the holding or the subsidiaries that are not recognized in the financial statements (see Note 53.2). As of December 31, 2022, 2021 and 2020 there was no contingent liability in connection with the investments in joint ventures and associates (see Note 53.2). ImpairmentAs required by IAS 36, the book value of the associates and joint venture entities has been compared with their recoverable amount, with the latter being calculated as the higher between the value in use and the fair value minus the cost of sale. For the year ended December 31, 2022, a reversal of impairment was recorded for €42 million; while for the year ended December 31, 2021, there was no impairment recorded in the Group’s consolidated income statement; and for the year ended December 31, 2020, €190 million were recorded due to impairment (see Note 48).

X
- Definition Disclosure of Investments In Subsidiaries Joint Ventures And Associates + References No definition available. + Details
Name: | bbva_DisclosureOfInvestmentsInSubsidiariesJointVenturesAndAssociatesTextBlock
Namespace Prefix: | bbva_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociatesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration